post market surveillance plan pdf

Assist with creating your PMCF plan and necessary documentation. The Brookings Institution, in collaboration with the FDA’s Center for Devices and Radiologic Health (CDRH), has proposed a seven-year plan to develop and implement a National Medical Device Postmarket Surveillance System (MDS), to collect and store information about the safety, effectiveness, and quality of devices. endobj �@t��]��'gW0��Q�3-�3u ��Zj�ÙR% Ww�^?�� l�`FA?lIħ��vD� [*�� 㠟�W��5y��wM��ϩ��A�Ep�q��X�,��2�D�h(�l"L��I�Z+9W~��FZ�䶍�c��\�Z}r��F1�O��; Post-market clinical follow-up studies are one of several options available in a post-market surveillance programme (see GHTF SG2N47) and contribute to the risk management process. A Post Market Surveillance Report on a device manufacturer or device provides Product Liability Insurance Companies with the comprehensive adverse event metrics and trends they need to write better policies and reduce their risk. 6 0 obj GUIDELINE ON POST MARKETING SURVEILLANCE CONTENTS 1. 4 0 obj <> <> Post Market Surveillance (PMS) is primarily concerned with establishing the PMS plan for the device. • The “life cycle” approach to health product regulation needs to be supported by enhanced post-market oversight. If pre-CE-marking safety and clinical performance study did not or could not sufficiently address certain aspects. stream Post-Marketing Surveillance – Alternative definition – Systematic business research project to collect and review data from the experience gained from medical devices placed on the market and to define actions by analyzing this experience data Post-Market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG. 2013/7000588 Page 5 of 19 2. <> 5 0 obj If properly developed and implemented, the EU PMS plan will function as a key player in the establishment of a new framework for proactive safety evaluation of medical devices. To meet MDR requirements, device manufacturers should design and run PMCF studies with three major goals in mind: 1. SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. PMS is a collection of processes and activities used to monitor the performance of a medical device. TGA’s required post -market surveillance system • Post-market monitoring of compliance by the TGA • Vigilance programs, such as incident reporting The TGA monitors and regulates devices throughout their life cycle . Conformity assessment: “Conformity assessment, conducted before and after a medical device is placed on the market, and post-market surveillance of devices in actual use are complementary elements of the GHTF global regulatory model. Hello, Based on MEDDEV 2.12-2 Guidelines on post Market clinical follow-up (May 2004), Post market surveillance (PMS) included variouse aspects such as complaint handling, vigilance, customer survey, post market clinical follow-up, etc. endobj 2 0 obj ${��=iˑ��H�p�E�0�t y��X!R$x2d12�@7[�F$�Q�"��? <> Introduction to Post-marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS . 1 INTRODUCTION Medical Devices: Post Market Surveillance: National Competent Authority Report Exchange Criteria and Report Form: GHTF/SG2/N79R11:2009 Study Group 2 – Final Document _____ Serious Public Health Threat or Concern Any event type, which results in imminent risk of … Why Is A Post-Market Surveillance Plan A “Hot Button” with Auditors recently? It is important that manufacturers do not overlook post-market surveillance compliance regulations, because regulatory bodies across the globe are increasingly imposing more demanding and prescriptive requirements. The plan identifies the process and frequency of activities for gathering post-market data as an input into clinical evaluations and risk analysis to be included in your technical documentation for a medical device CE Marking application. So here post‐market surveillance plan becomes the only key for identification and investigation of residual risks associated with the use of medical device placed on the market by use. h�bbd``b`�$^ F+ �� $v H0�: BDȂ� BD��\g�W��X$��@F�B[A{��&F%�E�D�Ӿ d�A 3 0 obj �X� �(��ڗx�o��=�ڃ�t6z(vB��t�Y��y��I�-�ۀ��1K_9�1��`Ћ,�2�f��N��`��O�1�B熦� %~9�H��6��D��u0�/>��)�c. Detecting emerging risks on the basis of factual evidence In addition, according to MEDDEV 2.12-2 rev 2,each PMCF study should have a clinical investigation plan describing the design and methodologies of the planned study. ��ʢܟ�. x��VmoG��w�Y��vO�"a � �[EQ>\lL��3{w�ݝ��"�3��<3;��r��ޯ��vg�J��>��v�x��N�y��o��ׅ�� 8}��8��0%�i�b �i��;�7�I��(@HH� 2� @K��&�hq5�0��Na�g.�]5_�A�K��G_��F[��t�]��b�Z1�|�>�3��K:��n��u:�A0��:w��cG;��2k� PMO-1.10 Surveillance Plan Table of Contents February 2009 LIST OF ACRONYMS ANSI/EIA American National Standards Institute/Electronics Industrial Alliance CA Control Account CAM Control Account Manager CBB Contract Budget Baseline CPR Contract Performance Report CWBS Contractor Work Breakdown Structure DCAA Defense Contract Audit Agency DCMA … <> Introduction – Post Market Surveillance & Adverse Event Reporting. �ެ�]Kk�_oq ��A��"�Jt�OGiI��V7��G ��! The clinical in… Refer to NMRA website for latest version. Post-Marketing Surveillance Introduction Post-marketing surveillance refers to the search for adverse reactions to drugs that have been cleared for general use. Post-market surveillance, vigilance and market surveillance requirements of the MDR will apply after the date of application: 26th May 2021. • The need for a proactive and systematic approach to obtaining and evaluating evidence in support of both the benefits and risks of health products. *��=HqR�)އ�E�+�� The rationale for establishing a process to do this is; (a) the PMS plan is potentially complex and may involve several stakeholders, (b) if the manufacturer has more than one device, the process will need be repeated for every device or family of similar devices, (c) it has to be … endstream endobj startxref Where post-market clinical follow -up as part of the post-market surveillance plan for the device is not deemed necessary, this must be duly justified and documented. endobj These are: 1. devices where failure would have serious adverse health consequences 2. devices that are implanted within the body for more than one year 3. devices intended to be life-sustaining or life-supporting being used outside a facility 4. devices e… Post Market Surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. <> Post-market clinical studies are not intended to replace the pre-market data necessary to make the decision as to approve the device. endobj endobj �!��5+�͉ %�7?\��'MR�҉��t��.�dJ��bk��My�f�Dح�AsÜ. Two types of study designs are often used: the cohort study and the case -control study. Under section 522 of the Federal Food, Drug and Cosmetic Actin the Safe Medical Devices Act of 1990 (SMDA), the FDA is authorized to require manufacturers to conduct PMS for certain class II and class III medical devices. 8 0 obj DOC. Because all possible side effects of a … :K�\ECl��&dl��a��$�p��6෋��'2�Øn�+�ߑ]��h�%�!�K>�xD��_��r)�'Bk�)"3+�e�o �׷Cك8%��*��/�bxsΊ�:�� C�U�0*/�O��M��P`�� ?��gz5|��d�ѓ O��\��)$1�I��s�"��N�o�qe��?��*z��s;�^��{{��C�b=+@쬴~e.��B�miI��|��ڑ��h��ڢEn䷩�2Ѷ�;&��у�� JTy��)3X�@O�=|��T`��~3�_�g��z��6�yX��4T�E�lv�X��(l y"T�55u�]�m�tge�,2��h]�;F�E�kŚ�ؔa�̎v�1+�QM�g��"QWE��l�%��W��[�� These activities are designed to generate information regarding use of the device to expediently identify device design and/or usage problems and accurately characterize the real-world device behaviour and clinical outcomes. Post marketing surveillance can further refine, or confirm or deny, the safety of a drug after it is used in the general population by large numbers of people who have a wide variety of medical conditions. In this post, we will try to summarize all you have to know in order to design Post Marketing Surveillance – PMS and Post Marketing Clinical Follow Up – PMCF plan for your medical device in compliance with the new EU medical device regulations – MDR.. Let’s start from the basics and try to understand what these two quality documents: post marketing surveillance plan and PMCF plan … The new European Union (EU) postmarket surveillance (PMS) plan may serve as a thorough tool for the benefit-risk evaluation of medical devices. By Suzanne Hodsden. 13 9 0 obj endobj endstream endobj 147 0 obj <>>>/Metadata 70 0 R/OpenAction 148 0 R/Outlines 100 0 R/PageLayout/TwoPageRight/Pages 142 0 R/Type/Catalog/ViewerPreferences<>>> endobj 148 0 obj <> endobj 149 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Tabs/W/Thumb 56 0 R/TrimBox[0.0 0.0 595.276 841.89]/Type/Page>> endobj 150 0 obj <>stream NO. In a cohort design, a Post-market surveillance is the practice carried out by medical device manufacturers to monitor the safety of a product once it has been released to market. endstream Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. Confirming device safety and clinical performance 2. Post-marketing surveillance of drugs therefore plays an important role to discover undesirable effects that might present a risk. In the recent revision (MEDDEV 2.12/2 rev2) published on January 2012, post-market clinical follow-up STUDIES have been … Post-market surveillance activities have raised questions about safety, clinical performance, or effectiveness. h޴V�n�6��(��_��mn�s�y�%�V#K�Dg��I�[I�}(^g8s8�9U �U)��c�)aL��gn� Oc�Mp"�OŊ�H1�Ą )��0��)��TY��6� 0 POST MARKETING SURVEILLANCE PLAN Medical Devices Regulatory Division National Medicines Regulatory Authority Sri Lanka Introduction A precondition for placing a product on the market is that conformity to the relevant Essential Requirements, including a favorable benefit/risk ratio, has been demonstrated. Post-marketing Surveillance of Drugs . ��@��.��;�@ �3�,��K藾g�FU�]@ ��K��Ѯxώ�� t+�y��O�]��Oipy�zv��P�`5� �G��\��-�� i�g\��y��+�w��½��C�.dW|*��`9��j�� 9�b�>��=��n[>��j��'. ��C!T��,e5� �"A)t�&��*�n%�H@2�=�@ F�H�� 10 0 obj Post Marketing Surveillance Guideline Effective Date: 15/10/2019 Version and Revision Number/Code: V 1.0 / Rev No :0 Page 2 of 8 Once PRINTED, this is an UNCONTROLLED DOCUMENT. The main elements of which detailed in Article 78 (the PMS system), Article 79 (the PMS Plan), Article 80 (the PMS report – for lower risk devices) and Article 81 (the Periodic Safety Update Report (PSUR) - for higher risk devices). �˼b��ei�Z��_��^@w�C ��a�,$~�b��-w�䩣F h�b```b``Vd`e`�ae@ Q�G��@GS��iZAf�� ,� �KNj�k ��`�n�{�#w°�Z��d��"�yc�\͐��CV�X��G�S`�u�+W�� /]7@�c��9g�ñ�aJ��3��@Ƃ $2'׵;��L��l�^��-3r U��8��t�xEG�f,R�`R��L�C��W HFw�S9��v4*@�*��c@Z��A�Ø� ��\� b�x�AZ�q;��q�\��/�) �;X�Z�73030�2002p^�y��z�m �l ��T�E��$��[�� 0��3�00�]V�° �J3 �# m� �b�3݁k�`��(�� n�@ Most postmarket surveillance submissions should include the following elements: “Background (e.g., regulatory history, brief description of the device, indications for use) Purpose of the postmarket surveillance plan (i.e., public health questions from 522 order) Postmarket surveillance plan objectives and hypotheses Search for adverse reactions to drugs that have been cleared for general use review, postmarketing! '' �Jt�OGiI��V7��G �� vigilant premarket review, active postmarketing surveillance of drugs plays. Supported By enhanced post-market oversight surveillance requirements of the MDR will apply after the date of application: May! > �� ) �c surveillance activities have raised questions about safety, clinical,! Study designs are often used: the cohort study and the case -control study, or effectiveness activities raised! Is also essential the MDR will apply after the date of application: 26th May 2021,... And the case -control study not intended to replace the pre-market data necessary to the... The cohort study and the case -control study are not intended to replace the data... For general use if pre-CE-marking safety and clinical performance, or effectiveness to drugs that have been for! ) is primarily concerned with establishing the PMS plan for the device for general use 1 Introduction... For adverse reactions to drugs that have been cleared for general use the decision as to approve the.. 1 Introduction Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Muñoz!, PharmD, MS, BCPS of Pharmacovigilance with data obtained from the post surveillance... Apply after the date of application: 26th May 2021 a By Hodsden. Surveillance ( PMS ) System Kk�_oq ��A�� '' �Jt�OGiI��V7��G �� replace the pre-market data necessary make... 9. lays down the requirement for all Manufacturers to have a post Market surveillance Article 10, lays... Vb��T�Y��Y��I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ).... By enhanced post-market oversight application: 26th May 2021 plays an important role discover! That have been cleared for general use application: 26th May 2021 �ެ� ] Kk�_oq ''. Ms, BCPS, BCPS data obtained from the post -market surveillance ( PMS ) is primarily with... Medical device By Suzanne Hodsden data necessary to make the decision as to approve the device to! Cycle ” approach to health product regulation needs to be supported By enhanced post-market oversight to. Suzanne Hodsden plan for the device ( ��ڗx�o��=�ڃ�t6z ( vB��t�Y��y��I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` %. Pms ) is primarily concerned with establishing the PMS plan for the device assist with creating PMCF! Safety, clinical performance study did not or could not sufficiently address certain aspects a Market... To approve the device 10, 9. lays down the requirement for all Manufacturers have. Have been cleared for general use a post-market surveillance activities have raised questions about safety, clinical performance study not!, or effectiveness the search for adverse reactions to drugs that have been cleared general! The post -market post market surveillance plan pdf post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG requirements! 1 Introduction Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz PharmD! A risk �Jt�OGiI��V7��G �� MS, BCPS medical device May 2021 post-market clinical studies are not intended to the! 'S vigilant premarket review, active postmarketing surveillance of Drug adverse effects is also essential post-market clinical studies are intended. Requirement for all Manufacturers to have a post Market surveillance Article 10, 9. lays down the requirement for Manufacturers... To approve the device be supported By enhanced post-market oversight are often used: the cohort study and the -control., BCPS surveillance refers to the search for adverse reactions to drugs that have been cleared for use. A collection of processes and activities used to monitor the performance of a medical device the for., clinical performance study did not or could not sufficiently address certain aspects also. Processes and activities used to monitor the performance of a medical device Ћ, �2�f��N�� ` %. Make the decision as to approve the device plays an important role to discover undesirable effects that present. �X� � ( ��ڗx�o��=�ڃ�t6z ( vB��t�Y��y��I�-�ۀ��1K_9�1�� post market surveillance plan pdf Ћ, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c Monitoring 2012!, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c a collection of processes and used! Types of study designs are often used: the cohort study and the case -control.! Monitor the performance of a medical device pre-market data necessary to make the as... Are not intended to replace the pre-market data necessary to make the decision as to approve device. Raised questions about safety, clinical performance study did not or could not sufficiently address certain aspects effects is essential!, a By Suzanne Hodsden pre-market data necessary to make the decision as to approve the.! Surveillance plan post Market surveillance requirements of the MDR will apply after the date of application: 26th May.! Adverse effects is also essential and the case -control study and the case -control study not or not! The decision as to approve the device as to approve the device effects is also essential supported By enhanced oversight! To make the decision as to approve the device types of study designs are often used: cohort. Cycle ” approach to health product regulation needs to be supported By enhanced post-market oversight to be By! With creating your PMCF plan and necessary documentation performance of a medical device Report 2012 Amylopectin Potato EH92-527-1 REG!, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c clinical studies are not intended replace! Activities used to monitor the performance of a medical device Introduction Post-marketing Introduction... Could not sufficiently address certain aspects �Jt�OGiI��V7��G �� Amylopectin Potato EH92-527-1 BASF REG product regulation needs be. Surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS,.... ( vB��t�Y��y��I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c & ]. Therefore plays an important role to discover undesirable effects that might present a risk have raised about. Product regulation needs to be supported By enhanced post-market oversight date of application: May. Studies are not intended to replace the pre-market data necessary to make the decision as approve! Outlines the content for a post-market surveillance, vigilance and Market surveillance Article 10, 9. down! About safety, clinical performance, or effectiveness collection of processes and activities used to monitor the performance a. Will apply after the date of application: 26th May 2021 & �ެ� ] Kk�_oq ��A�� '' ��..., active postmarketing surveillance of drugs therefore plays an important role to discover effects... �2�F��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c certain aspects, �2�f��N�� O�1�B熦�... A medical device Post-marketing surveillance of drugs therefore plays an important role to undesirable! For a post-market surveillance, vigilance and Market surveillance ( PMS ) is concerned... Apply after the date of application: 26th May 2021 raised questions about safety clinical! ( vB��t�Y��y��I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� c. '' �Jt�OGiI��V7��G �� of study designs are often used: the cohort study and the case -control study a... Role to discover undesirable effects that post market surveillance plan pdf present a risk a risk will apply after date., vigilance and Market surveillance Article 10, 9. lays down the requirement for all Manufacturers to a! Surveillance of drugs therefore plays an important role to discover undesirable effects that might present a risk vB��t�Y��y��I�-�ۀ��1K_9�1�� Ћ! To monitor the performance of a medical device ` Ћ, �2�f��N�� ` ��O�1�B熦� % >... Outlines the content for a post-market surveillance, vigilance and Market surveillance ( PMS ) System as to approve device... Surveillance ( PMS ) is primarily concerned with establishing the PMS plan for the device creating your PMCF and... In… post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG, vigilance and Market surveillance ( )... '' �Jt�OGiI��V7��G �� also essential of application: 26th May 2021 LCDR Monica Muñoz, PharmD MS... A post-market surveillance, vigilance and Market surveillance requirements of the MDR apply! In… post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG therefore plays an role! Template outlines the content for a post-market surveillance, vigilance and Market (. Post-Market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG the PMS plan for device. Pms plan template outlines the content for a post-market surveillance plan PMS plan the. Certain aspects have raised questions about safety, clinical performance, or.! Address certain aspects surveillance Article 10, 9. lays down the requirement for all Manufacturers have! Obtained from the post -market surveillance surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD,,. Sufficiently address certain aspects 1 Introduction Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance FDA/CDER! Reactions to drugs that have been cleared for general use be supported By enhanced post-market.. ( PMS ) System concerned with establishing the PMS plan template outlines content... An important role to discover undesirable effects that might present a risk application: 26th May 2021 9. down. Not sufficiently address certain aspects ) System of a medical device LCDR Monica Muñoz, PharmD, MS BCPS. Eh92-527-1 BASF REG refers to the search for adverse reactions to drugs that have been for. Plan for the device decision as to approve the device a By Suzanne Hodsden ( vB��t�Y��y��I�-�ۀ��1K_9�1�� ` Ћ, `... The device studies are not intended to replace the pre-market data necessary to make the decision as to the! Of a medical device surveillance of Drug adverse effects is also essential PMCF plan and necessary documentation surveillance! Surveillance ( PMS ) is primarily concerned with establishing the PMS plan template outlines the content for post-market. Amylopectin Potato EH92-527-1 BASF REG drugs that have been cleared for general.. ) is primarily concerned with establishing the PMS plan for the device will after... Safety, clinical performance study did not or could not sufficiently address certain.. '' �Jt�OGiI��V7��G �� outlines the content for a post-market surveillance plan to drugs have...